Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine in adolescents with idiopathic Restless Legs Syndrome
NCT03728933Phase 3Terminated
- Sponsor
- UCB
- Start
- Dec 2018
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rotigotine in restless legs syndrome (RLS), sponsored by UCB. Started Dec 2018; status: terminated.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT03728933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03728933.